EricLMattesonMD

Rheumatoid Arthritis & Related, Spondyloarthropathy, Vasculitis

Consultant, Chair, Division of Rheumatology, Mayo Clinic

Dr. Matteson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
200 1st St SW
Rochester, MN 55905
Phone+1 507-284-2511

Fax+1 507-255-3125

Dr. Eric Matteson is a rheumatologist in Rochester, MN and is affiliated with Mayo Clinic Hospital - Rochester. He received his medical degree from University of Erlangen- Nuremberg Faculty of Medicine and has been in practice 35 years. He specializes in rheumatoid arthritis & related, spondyloarthropathy, and vasculitis.. He is retired from clinical practice.

University of North Carolina HospitalsFellowship, Public Health and General Preventive Medicine, 1989 - 1990
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Rheumatology, 1988 - 1989
University of MichiganFellowship, Rheumatology, 1986 - 1988
Western Michigan University Homer Stryker MD School of MedicineResidency, Internal Medicine, 1983 - 1986
University of Erlangen - Nuremberg Faculty of MedicineClass of 1982

PubMed

3824 citations
2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
John Charles Jennette, Ronald Falk, P. A. Bacon, Neil Basu, Maria C. Cid
Arthritis and Rheumatism. 2013-01-01
124 citations
Progressive Decline of Lung Function in Rheumatoid Arthritis-Associated Interstitial Lung Disease
Jorge A. Zamora-Legoff, Megan L. Krause, Cynthia S. Crowson, Jay H. Ryu, Eric L. Matteson
Arthritis & Rheumatology. 2017-03-01
112 citations
Methotrexate and rheumatoid arthritis associated interstitial lung disease.
Pierre-Antoine Juge, Joyce S. Lee, Jessica Lau, Leticia Kawano-Dourado, Jorge Rojas Serrano
The European Respiratory Journal. 2021-02-01

Journal Articles

MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease
Jay H Ryu, Deborah Assayag, Marvin I Schwarz, Paul Wolters, Andrew Gross, Ivan O Rosas, Aryeh Fischer, Michael Holers, Eric L Matteson, Timothy B Niewold, The New England Journal of Medicine

Other

Polymyalgia Rheumatica and Giant Cell Arteritis
Eric Matteson, MD, JAMA
https://www.doximity.com/articles/7ee16cad-211f-44f7-a6b4-d18555291beb
UpToDate, Wolters Kluwer Health - 2012-12-17
Prevention of Glucocorticoid Morbidity in Giant Cell Arteritis
Eric Matteson, MD, Rheumatology
https://www.doximity.com/articles/da91256c-6819-48b7-884a-8b2373d6753d
UpToDate, Wolters Kluwer Health - 2013-01-14

Treatments for Giant Cell Arteritis: Meta-Analysis and Assessment of Estimates Reliability Using the Fragility IndexJanuary 2018

New Study Finds Rheumatology Prescribing, Spending Linked to Pharmaceutical PaymentsApril 19th, 2022
Nintedanib Slows FVC Decline in Autoimmune-Related Interstitial Lung DiseaseFebruary 24th, 2022
Is Rheumatoid Arthritis Genetic—and Does Family History Boost Your Risk?August 11th, 2021
Join now to see all

Genetic Polymorphisms In Rheumatoid ArthritisNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2004
Genetic Polymorphisms In Rheumatoid ArthritisNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2002–2003
Two Week Induction Course &One Maintenance Cycle Of Ag4263National Center For Research Resources1999–2002
Induction Therapy For Treatment Of Refractive, Active Rheumatoid ArthritisNational Center For Research Resources1998–1999
Study Of Campath-1h In Active Refractory Rheumatoid ArthritisNational Center For Research Resources1993
OPEN Label Protocol Of Campath 1H In The Treatment Of Rheumatoid ArthritisNational Center For Research Resources1993